Guidelines for preventing the transmission of tuberculosis in Canadian Health Care Facilities and other institutional settings.
D000995:Antitubercular Agents / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D058016:Health Facility Administration; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D007538:Isoniazid / Q000627:therapeutic use; D016273:Occupational Exposure; D011481:Protective Clothing; D012307:Risk Factors; D014376:Tuberculosis / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission*
D000995:Antitubercular Agents; D007538:Isoniazid